These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 992045)

  • 1. Anticoagulant activity of heparin: isolation of antithrombin-binding sites.
    Hopwood J; Höök M; Linker A; Lindahl U
    FEBS Lett; 1976 Oct; 69(1):51-4. PubMed ID: 992045
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
    Höök M; Björk I; Hopwood J; Lindahl U
    FEBS Lett; 1976 Jul; 66(1):90-3. PubMed ID: 1278445
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
    Pejler G; Danielsson A; Björk I; Lindahl U; Nader HB; Dietrich CP
    J Biol Chem; 1987 Aug; 262(24):11413-21. PubMed ID: 3624220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-activity heparin: chain length, affinity for antithrombin, and anticoagulant activity.
    Radoff S; Danishefsky I
    Arch Biochem Biophys; 1982 Apr; 215(1):163-70. PubMed ID: 7092223
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin with two binding sites for antithrombin or platelet factor 4.
    Jordan RE; Favreau LV; Braswell EH; Rosenberg RD
    J Biol Chem; 1982 Jan; 257(1):400-6. PubMed ID: 7053378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uronic acid composition of anticoagulantly active and inactive heparin.
    Rosenfeld L; Radoff S; Danishefsky I
    Arch Biochem Biophys; 1985 Nov; 242(2):574-8. PubMed ID: 4062296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of heparin with proteins. Demonstration of different binding sites for antithrombin and lipoprotein lipase.
    Bengtsson G; Olivecrona T
    FEBS Lett; 1977 Jul; 79(1):59-63. PubMed ID: 891935
    [No Abstract]   [Full Text] [Related]  

  • 10. Highly active heparin species with multiple binding sites for antithrombin.
    Rosenberg RD; Jordan RE; Favreau LV; Lam LH
    Biochem Biophys Res Commun; 1979 Feb; 86(4):1319-24. PubMed ID: 571279
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of critical groups required for the binding of heparin to antithrombin.
    Atha DH; Stephens AW; Rosenberg RD
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1030-4. PubMed ID: 6583694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.
    Horner AA
    Biochem J; 1986 Nov; 240(1):171-9. PubMed ID: 3827837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.
    Horner AA; Kusche M; Lindahl U; Peterson CB
    Biochem J; 1988 Apr; 251(1):141-5. PubMed ID: 3390150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.
    Horner AA
    Biochem J; 1989 Sep; 262(3):953-8. PubMed ID: 2590178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of heparin with thrombin and antithrombin III.
    Feinman RD; Li EH
    Fed Proc; 1977 Jan; 36(1):51-5. PubMed ID: 830556
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.